SCHEMBL4599726

SCHEMBL4599726

Cc1ccc(S(=O)(=O)Oc2ccc(CC[C@H]3CNC(=O)CO3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP1 P22413 3/20 0.44
ALDH1A1 P00352 3/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
PPARG P37231 1/20 0.39
MGAM O43451 1/20 0.38
ALPL P05186 1/20 0.38
ENPP3 O14638 2/20 0.38
ENPP2 Q13822 2/20 0.38
CA12 O43570 1/20 0.36
CA2 P00918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4599439 1.00 ENPP1 (0.44) ENPP1ALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL4782480 0.81 CA12 (0.39) ALDH1A1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2294885 0.79 ALDH1A1 (0.49) ENPP1ALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL2294738 0.79 ALDH1A1 (0.49) ENPP1ALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL14290873 0.78 ALDH1A1 (0.39) ALDH1A1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL4777682 0.78 ALDH1A1 (0.39) ALDH1A1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL15936332 0.72 ENPP1 (0.55) ENPP1ALDH1A1LMNASMN1; SMN2HTT
SCHEMBL6937915 0.72 ENPP1 (0.58) ENPP1ALDH1A1MEN1MAPTHTT
SCHEMBL2293187 0.69 MAOB (0.45) ENPP1ALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL2296879 0.69 MAOB (0.45) ENPP1ALDH1A1CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed